Google
Trusted Resources: News & Events
Latest announcements and gatherings
Expert Opinion Hydroxyurea Could Prevent Strokes for People With Sickle Cell Disease in Lieu of Transfusions During COVID-19 Blood Supply Shortage
The COVID-19 pandemic threatens to cause a blood supply shortage in the United States, and as a result, clinicians may be compelled to ration or conserve blood products. For people living with sickle cell disease (SCD), blood transfusions are often necessary to decrease the frequency of severe symptoms.
In a new Blood paper, Michael R. DeBaun, MD, MPH, of Vanderbilt University Medical Center, Vanderbilt-Meharry Sickle Cell Disease Center of Excellence, suggests that while monthly blood transfusions are the standard method of stroke prevention for children with SCD and at high risk of strokes, initiation of hydroxyurea therapy may be an effective alternative, if the monthly blood transfusions are interrupted.
+myBinderRelated Content
-
Coronavirus, Racial Disparity in Sickle Cell DiseaseDespite being a rare condition, sickle c...
-
COVID-19: Highest Risk Patients are Asked to Stay at Home for 12 Weeks [England]A million and a half people in England w...
-
The Caregiver Experience With Carley Cole Cavins – WebinarThe Sickle Cell Mental Health Initiative...
-
Coronavirus (COVID-19) & Sickle Cell DisorderCOVID-19 is a new illness that can affec...
-
Mental Health, Grief, and Sickle Cell Disease – WebinarThe Sickle Cell Mental Health Initiative...
-
Sickle Cell Disease Association of America Extends its COVID-19 Emergency FundraiserThe Sickle Cell Disease Association of A...
-
COVID-19 Health Alert for Patients and Caregivers – SCDAAMay 27, 2020 – COVID-19, the coronav...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.